ProfileGDS4132 / 202108_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 81% 81% 82% 83% 78% 76% 76% 80% 77% 78% 81% 81% 79% 83% 74% 79% 75% 81% 79% 77% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101273.51381
GSM201543Muscle PCOS pioglitazone 121267.98381
GSM201544Muscle PCOS pioglitazone 161304.7782
GSM201545Muscle PCOS pioglitazone 201326.45283
GSM201829Muscle PCOS pioglitazone 231268.03778
GSM201830Muscle PCOS pioglitazon 251248.46476
GSM201831Muscle PCOS pioglitazone 271253.82576
GSM201832Muscle PCOS pioglitazone 31263.22280
GSM201833Muscle PCOS pioglitazone 41244.07777
GSM201834Muscle PCOS pioglitazone 81262.72178
GSM201835Muscle PCOS after pioglitazone 102289.06181
GSM201836Muscle PCOS after pioglitazone 122283.31981
GSM201837Muscle PCOS after pioglitazone 162253.27779
GSM201838Muscle PCOS after pioglitazone 202324.40983
GSM201839Muscle PCOS after pioglitazone 232234.86974
GSM201840Muscle PCOS after pioglitazone 252280.36579
GSM201841Muscle PCOS after pioglitazone 272225.56875
GSM201842Muscle PCOS after pioglitazone 32265.35181
GSM201843Muscle PCOS after pioglitazone 42263.6479
GSM201844Muscle PCOS after pioglitazone 82264.19177